Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Malignant Lymphoma

Free Subscription Articles published in Leuk Lymphoma Retrieve available abstracts of 398 articles: HTML format

Single Articles

April 2008
1. LAI R , Bartlett NL, Mackey JR, Jung SH, et al
   High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - A CALGB 59804 correlat
   Leuk Lymphoma. 2008;:1-4.
   PubMed     Related articles   
   
   
   
2. OKI Y , Kato H, Matsuo K, Kuwatsuka Y, et al
   Prognostic value of serum soluble interleukin-2 receptor level in patients with diffuse large B cell lymphoma, treated with CHOP- or RCHOP-based therapy.
   Leuk Lymphoma. 2008;:1-7.
   PubMed     Related articles    Abstract available
   
   
   
3. LOONG SL , Hwang JS, Lim ST, Yap SP, et al
   An Epstein-Barr virus positive natural killer lymphoma xenograft derived for drug testing.
   Leuk Lymphoma. 2008;:1-7.
   PubMed     Related articles    Abstract available
   
   
   
4. REHMAN JU , Burney IA, Kindi SA, Raeburn S, et al
   Familial lymphoma in an Omani kindred with identical class II HLA type.
   Leuk Lymphoma. 2008;:1-4.
   PubMed     Related articles   
   
   
   
5. FALORIO S , Angrilli F, Fioritoni G
   Gonadotropin-releasing hormone analog treatment for the prevention of treatment-related ovarian failure and infertility in women of reproductive age with Hodgkin lymphoma.
   Leuk Lymphoma. 2008;:1-7.
   PubMed     Related articles    Abstract available
   
   
   
6. HUMPHREYS MR , Cino M, Quirt I, Barth D, et al
   Long-term survival in two patients with hepatosplenic T cell lymphoma treated with interferon-alpha.
   Leuk Lymphoma. 2008;:1-4.
   PubMed     Related articles   
   
   
   
7. TILL BG , Gooley TA, Crawford N, Gopal AK, et al
   Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.
   Leuk Lymphoma. 2008;:1-12.
   PubMed     Related articles    Abstract available
   
   
   
8. PALTIEL O
   Family matters in Hodgkin lymphoma.
   Leuk Lymphoma. 2008;:1-2.
   PubMed     Related articles   
   
   
   
9. THELANDER EF , Rosenquist R
   Molecular genetic characterization reveals new subsets of mantle cell lymphoma.
   Leuk Lymphoma. 2008;:1-8.
   PubMed     Related articles    Abstract available
   
   
   
10. RODRIGUEZ J , Gutierrez A, Piris M
    Primary mediastinal B-cell lymphoma: Treatment and therapeutic targets.
    Leuk Lymphoma. 2008;:1-12.
    PubMed     Related articles    Abstract available
    
    
    
11. DREYLING M
    Hyper-CVAD in mantle-cell lymphoma: Really "hyper" or just hype?
    Leuk Lymphoma. 2008;:1-2.
    PubMed     Related articles   
    
    
    
12. OKI Y , Younes A
    Current role of gemcitabine in the treatment of Hodgkin lymphoma.
    Leuk Lymphoma. 2008;:1-7.
    PubMed     Related articles    Abstract available
    
    
    
13. KIAN TC , Miriam T, Richard Q, Peng YS, et al
    Clinical characteristics, prognostic factors and outcomes of Burkitt lymphoma in adult Asians.
    Leuk Lymphoma. 2008;49:824-7.
    PubMed     Related articles   
    
    
    
14. RIZZATTI EG , Mora-Jensen H, Weniger MA, Gibellini F, et al
    Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathways.
    Leuk Lymphoma. 2008;49:798-808.
    PubMed     Related articles    Abstract available
    
    
    
15. ADAMS DJ , Sandvold ML, Myhren F, Jacobsen TF, et al
    Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.
    Leuk Lymphoma. 2008;49:786-97.
    PubMed     Related articles    Abstract available
    
    
    
16. AKHTAR S , Weshi AE, Rahal M, Khafaga Y, et al
    Factors affecting autologous peripheral blood stem cell collection in patients with relapsed or refractory diffuse large cell lymphoma and Hodgkin lymphoma: a single institution result of 168 patients.
    Leuk Lymphoma. 2008;49:769-78.
    PubMed     Related articles    Abstract available
    
    
    
17. KIKUCHI A , Mori T, Fujimoto J, Kumagai M, et al
    Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol.
    Leuk Lymphoma. 2008;49:757-62.
    PubMed     Related articles    Abstract available
    
    
    
18. REDDY K , Ansari-Lari M, Dipasquale B
    Blastic mantle cell lymphoma with a Burkitt translocation.
    Leuk Lymphoma. 2008;49:740-50.
    PubMed     Related articles    Abstract available
    
    
    
19. TSURUSAWA M , Taga T, Horikoshi Y, Ogawa A, et al
    Favourable outcomes in children with diffuse large B-cell lymphoma treated by a short-term ALL-like regimen: a report on the NHL960 study from the Japanese Childhood Cancer and Leukemia Study Group.
    Leuk Lymphoma. 2008;49:734-9.
    PubMed     Related articles    Abstract available
    
    
    
20. CROCCHIOLO R , Canevari C, Assanelli A, Lunghi F, et al
    Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation.
    Leuk Lymphoma. 2008;49:727-33.
    PubMed     Related articles    Abstract available
    
    
    
21. RUTHERFORD SC , Andemariam B, Philips SM, Elstrom RL, et al
    FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma.
    Leuk Lymphoma. 2008;49:719-26.
    PubMed     Related articles    Abstract available
    
    
    
22. ILLIDGE T , Tolan S
    Current treatment approaches for diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2008;49:663-76.
    PubMed     Related articles    Abstract available
    
    
    
23. GALLAMINI A , Hutchings M, Avigdor A, Polliack A, et al
    Early interim PET scan in Hodgkin lymphoma: where do we stand?
    Leuk Lymphoma. 2008;49:659-62.
    PubMed     Related articles    Abstract available
    
    
    
24. WEI AH , Roberts AW
    Bortezomib: putting mantle cell lymphoma on death row.
    Leuk Lymphoma. 2008;49:657-8.
    PubMed     Related articles   
    
    
    March 2008
25. CHRISTIE L , Kernohan N, Levison D, Sales M, et al
    C-MYC translocation in t(14;18) positive follicular lymphoma at presentation: An adverse prognostic indicator?
    Leuk Lymphoma. 2008;49:470-6.
    PubMed     Related articles    Abstract available
    
    
    
26. NGO L , Hee SW, Lim LC, Tao M, et al
    Prognostic factors in patients with diffuse large B cell lymphoma: Before and after the introduction of rituximab.
    Leuk Lymphoma. 2008;49:462-9.
    PubMed     Related articles    Abstract available
    
    
    
27. BURKHARDT B , Moericke A, Klapper W, Greene F, et al
    Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: Differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact.
    Leuk Lymphoma. 2008;49:451-61.
    PubMed     Related articles    Abstract available
    
    
    
28. COLEMAN M , Martin P, Ruan J, Furman R, et al
    Low-dose metronomic, multidrug therapy with the PEP-C oral combination chemotherapy regimen for mantle cell lymphoma.
    Leuk Lymphoma. 2008;49:447-50.
    PubMed     Related articles    Abstract available
    
    
    
29. O'MAHONY D , Debnath I, Janik J, Aisner D, et al
    Cardiac involvement with human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: The NIH experience.
    Leuk Lymphoma. 2008;49:439-46.
    PubMed     Related articles    Abstract available
    
    
    
30. GILL S , Ritchie D
    Therapeutic options in mantle cell lymphoma.
    Leuk Lymphoma. 2008;49:398-409.
    PubMed     Related articles    Abstract available
    
    
    
31. ALIZADEH AA , Lossos IS
    Double trouble in follicular lymphoma: A rare and unusual synergy of oncogenes in the germinal center.
    Leuk Lymphoma. 2008;49:377-80.
    PubMed     Related articles   
    
    
    
32. THELANDER EF , Ichimura K, Corcoran M, Barbany G, et al
    Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia.
    Leuk Lymphoma. 2008;49:477-87.
    PubMed     Related articles    Abstract available
    
    
    February 2008
33. RE D , Hartlapp I, Greiner A, Diehl V, et al
    Analysis of CARMA1/BCL10/MALT1 expression in Reed - Sternberg cells of classical Hodgkin lymphoma.
    Leuk Lymphoma. 2008;49:362-4.
    PubMed     Related articles   
    
    
    
34. CHUMSRI S , Zhao M, Garofalo M, Burger A, et al
    Inhibition of the mammalian target of rapamycin (mTOR) in a case of refractory primary cutaneous anaplastic large cell lymphoma.
    Leuk Lymphoma. 2008;49:359-61.
    PubMed     Related articles   
    
    
    
35. BURKE LP , Kukoly CA
    Statins induce lethal effects in acute myeloblastic lymphoma cells within 72 hours.
    Leuk Lymphoma. 2008;49:322-30.
    PubMed     Related articles    Abstract available
    
    
    
36. KCHOUR G , Tarhini M, Sharifi N, Farid R, et al
    Increased microvessel density in involved organs from patients with HTLV-I associated adult T cell leukemia lymphoma.
    Leuk Lymphoma. 2008;49:265-70.
    PubMed     Related articles    Abstract available
    
    
    
37. ETTO L , Lacerda E, Baiocchi O, Silva V, et al
    Clinical correlations and prognostic relevance of HGF, VEGF AND FGF expression in Brazilian patients with non-Hodgkin lymphoma.
    Leuk Lymphoma. 2008;49:257-64.
    PubMed     Related articles    Abstract available
    
    
    
38. LEE NR , Song EK, Jang KY, Choi HN, et al
    Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis.
    Leuk Lymphoma. 2008;49:247-56.
    PubMed     Related articles    Abstract available
    
    
    
39. HORNBERGER J , Reyes C, Lubeck D, Valente N, et al
    Economic evaluation of rituximab plus cyclophosphamide, vincristine and prednisolone for advanced follicular lymphoma.
    Leuk Lymphoma. 2008;49:227-36.
    PubMed     Related articles    Abstract available
    
    
    
40. AMRIA S , Cameron C, Stuart R, Haque A, et al
    Defects in HLA class II antigen presentation in B-cell lymphomas.
    Leuk Lymphoma. 2008;49:353-5.
    PubMed     Related articles   
    
    
    
41. SCHUTZINGER C , Esterbauer H, Hron G, Skrabs C, et al
    Prognostic value of T-cell receptor gamma rearrangement in peripheral blood or bone marrow of patients with peripheral T-cell lymphomas.
    Leuk Lymphoma. 2008;49:237-46.
    PubMed     Related articles    Abstract available
    
    
    
42. HUI D , Lam W, Toze C, Delorme M, et al
    Alemtuzumab in clinical practice: a British Columbia experience.
    Leuk Lymphoma. 2008;49:218-26.
    PubMed     Related articles    Abstract available
    
    
    
43. RIMSZA L
    Regulating the suppressors: helpful or harmful?
    Leuk Lymphoma. 2008;49:179-80.
    PubMed     Related articles   
    
    
    January 2008
44. 
    Reviewers for Leukemia & Lymphoma during 2007.
    Leuk Lymphoma. 2008;49:171-4.
    PubMed     Related articles   
    
    
    
45. THORNS C , Bernd HW, Krokowski M, Feller AC, et al
    Preservation of follicle mantle in follicular lymphoma.
    Leuk Lymphoma. 2008;49:166-7.
    PubMed     Related articles   
    
    
    
46. FOWLER N , Asatiani E, Cheson B
    Needle tract seeding after bone marrow biopsy in non-Hodgkin lymphoma.
    Leuk Lymphoma. 2008;49:156-8.
    PubMed     Related articles   
    
    
    
47. LIM ST , Hee SW, Quek R, Tao M, et al
    Performance status is the single most important prognostic factor in lymphoma patients aged greater than 75 overriding other prognostic factors such as histology.
    Leuk Lymphoma. 2008;49:149-51.
    PubMed     Related articles   
    
    
    
48. AL-DAYEL F , Al-Rasheed M, Ibrahim M, Bu R, et al
    Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population.
    Leuk Lymphoma. 2008;49:122-9.
    PubMed     Related articles    Abstract available
    
    
    
49. SHIZUSAWA T , Shibayama H, Murata S, Saitoh Y, et al
    The expression of anamorsin in diffuse large B cell lymphoma: Possible prognostic biomarker for low IPI patients.
    Leuk Lymphoma. 2008;49:113-21.
    PubMed     Related articles    Abstract available
    
    
    
50. KIMBY E , Jurlander J, Geisler C, Hagberg H, et al
    Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: A randomized phase II study from the Nordic Lymphoma Group.
    Leuk Lymphoma. 2008;49:102-12.
    PubMed     Related articles    Abstract available
    
    
    
51. DIAZ-ALDERETE A , Doval A, Camacho F, Verde L, et al
    Frequency of BCL2 and BCL6 translocations in follicular lymphoma: Relation with histological and clinical features.
    Leuk Lymphoma. 2008;49:95-101.
    PubMed     Related articles    Abstract available
    
    
    
52. PARK BB , Kim JS, Lee YY, Kang HJ, et al
    Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2008;49:88-94.
    PubMed     Related articles    Abstract available
    
    
    
53. TONG H , Ren Y, Liu H, Xiao F, et al
    Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: Comparison of T-cell lymphoma with and without hemophagocytic syndrome.
    Leuk Lymphoma. 2008;49:81-7.
    PubMed     Related articles    Abstract available
    
    
    
54. DUNPHY C , Tang W
    Usefulness of routine conventional cytogenetic analysis in tissues submitted for "lymphoma work-up".
    Leuk Lymphoma. 2008;49:75-80.
    PubMed     Related articles    Abstract available
    
    
    
55. ECONOMOPOULOS T , Psyrri A, Fountzilas G, Tsatalas C, et al
    Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: Promising results in marginal zone lymphoma.
    Leuk Lymphoma. 2008;49:68-74.
    PubMed     Related articles    Abstract available
    
    
    
56. ARMITAGE JO
    Is lymphoma occurring in the elderly the same disease?
    Leuk Lymphoma. 2008;49:14-6.
    PubMed     Related articles   
    
    
    
57. DREYLING M
    Combination of biologicals in indolent lymphoma: Finally the end of chemotherapy era in indolent lymphoma?
    Leuk Lymphoma. 2008;49:8-9.
    PubMed     Related articles   
    
    
    
58. ROSENWALD A , Ott G
    Is there still a point for classical cytogenetic banding analysis in the diagnostic work-up of specimens suspicious for lymphoma?
    Leuk Lymphoma. 2008;49:6-7.
    PubMed     Related articles   
    
    
    
59. POLLIACK A , van Besien K, Seymour JF
    2007: The year in review for Leukemia and Lymphoma.
    Leuk Lymphoma. 2008;49:1-3.
    PubMed     Related articles   
    
    
    
60. LIM SH , Esler WV, Zhang Y, Zhang J, et al
    B-cell depletion for 2 years after autologous stem cell transplant for NHL induces prolonged hypogammaglobulinemia beyond the rituximab maintenance period.
    Leuk Lymphoma. 2008;49:152-3.
    PubMed     Related articles   
    
    
    December 2007
61. CRUZ RI , Hernandez-Ilizaliturri FJ, Olejniczak S, Deeb G, et al
    CD52 over-expression affects rituximab-associated complement-mediated cytotoxicity but not antibody-dependent cellular cytotoxicity: Preclinical evidence that targeting CD52 with alemtuzumab may reverse acquired resistance to rituximab in non-Hodgkin lym
    Leuk Lymphoma. 2007;48:2424-36.
    PubMed     Related articles    Abstract available
    
    
    
62. KELLEY T , Beck R, Absi A, Jin T, et al
    Biologic predictors in follicular lymphoma: Importance of markers of immune response.
    Leuk Lymphoma. 2007;48:2403-11.
    PubMed     Related articles    Abstract available
    
    
    
63. GADI VK
    Chronic lymphocytic lymphoma: Another example of parental favoritism?
    Leuk Lymphoma. 2007;48:2306-7.
    PubMed     Related articles   
    
    
    
64. MARCUS R
    Distinguishing between entities - rationally based advances in the therapy of follicular lymphoma.
    Leuk Lymphoma. 2007;48:2285-6.
    PubMed     Related articles   
    
    
    
65. MENON S , Habermann T, Witzig T
    Lenalidomide-associated hypothyroidism.
    Leuk Lymphoma. 2007;48:2465-7.
    PubMed     Related articles   
    
    
    November 2007
66. 
    The abstracts to follow form an addendum to those already published in Leukemia & Lymphoma Volume 48 Supplement 1 (2007).
    Leuk Lymphoma. 2007;48:2264-74.
    PubMed     Related articles   
    
    
    
67. ENNISHI D , Yokoyama M, Mishima Y, Watanabe C, et al
    Rituximab plus CHOP as an initial chemotherapy for patients with disseminated MALT lymphoma.
    Leuk Lymphoma. 2007;48:2241-3.
    PubMed     Related articles   
    
    
    
68. LECH-MARANDA E , Baseggio L, Charlot C, Rigal D, et al
    Genetic polymorphisms in the proximal IL-10 promoter and susceptibility to non-Hodgkin lymphoma.
    Leuk Lymphoma. 2007;48:2235-8.
    PubMed     Related articles   
    
    
    
69. RODRIGUEZ J , Gutierrez A, Palacios A, Navarrete M, et al
    Rituximab, gemcitabine and oxaliplatin: An effective regimen in patients with refractory and relapsing mantle cell lymphoma.
    Leuk Lymphoma. 2007;48:2172-8.
    PubMed     Related articles    Abstract available
    
    
    
70. FINA M , Tani M, Stefoni V, Musuraca G, et al
    VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly.
    Leuk Lymphoma. 2007;48:2167-71.
    PubMed     Related articles    Abstract available
    
    
    
71. WIRTH A
    The rationale and role of radiation therapy in the treatment of patients with diffuse large B-cell lymphoma in the Rituximab era.
    Leuk Lymphoma. 2007;48:2121-36.
    PubMed     Related articles    Abstract available
    
    
    
72. WANG S
    Publishing on genes and lymphoma in the era of "big science".
    Leuk Lymphoma. 2007;48:2091-2.
    PubMed     Related articles   
    
    
    
73. MARCUS R
    Pathogenesis of MALT lymphoma: Implications for risk stratification and therapy.
    Leuk Lymphoma. 2007;48:2087-8.
    PubMed     Related articles   
    
    
    
74. SCHMIDT M
    PLK1 and survivin in diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2007;48:2089-90.
    PubMed     Related articles   
    
    
    
75. STROBEL ES , Bauchmuller K, Ihorst G, Engelhardt M, et al
    Frequency, severity and risk factors for oral mucositis after BEAM conditioning and autologous peripheral blood stem cell transplantation: A single center analysis and review of the literature.
    Leuk Lymphoma. 2007;48:2255-60.
    PubMed     Related articles   
    
    
    
76. PAZGAL I , Boycov O, Shpilberg O, Okon E, et al
    Expression of VEGF-C, VEGF-D and their receptor VEGFR-3 in diffuse large B-cell lymphomas.
    Leuk Lymphoma. 2007;48:2213-20.
    PubMed     Related articles    Abstract available
    
    
    
77. ROSADO M , Chao H, Rose M
    Severe acute thrombocytopenia following rituximab therapy.
    Leuk Lymphoma. 2007;48:2239-40.
    PubMed     Related articles   
    
    
    
78. GOTERI G , Ranaldi R, Simonetti O, Capretti R, et al
    Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association.
    Leuk Lymphoma. 2007;48:2184-8.
    PubMed     Related articles    Abstract available
    
    
    October 2007
79. KUZEL TM , Li S, Eklund J, Foss F, et al
    Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: Final results of E1497.
    Leuk Lymphoma. 2007;:1-6.
    PubMed     Related articles    Abstract available
    
    
    
80. LIU L , Zhang M, Zou P
    Expression of PLK1 and survivin in diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2007;:1-5.
    PubMed     Related articles    Abstract available
    
    
    
81. MAGAGNOLI M , Balzarotti M, Siracusano LV, Spina M, et al
    High relapse rate after a brief chemotherapy course and involved-field radiotherapy in early-stage Hodgkin lymphoma.
    Leuk Lymphoma. 2007;:1-3.
    PubMed     Related articles   
    
    
    
82. EMMANOUILIDES C
    Current treatment options in follicular lymphoma: Science and bias.
    Leuk Lymphoma. 2007;:1-12.
    PubMed     Related articles    Abstract available
    
    
    
83. IDE M , Fukushima N, Hisatomi T, Tsuneyoshi N, et al
    Non-germinal cell phenotype and bcl-2 expression in primary adrenal diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2007;:1-3.
    PubMed     Related articles   
    
    
    
84. SCHMIDT M
    Plk1 and survivin in diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2007;:1-2.
    PubMed     Related articles   
    
    
    
85. FRIDBERG M , Servin A, Anagnostaki L, Linderoth J, et al
    Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: Higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN.
    Leuk Lymphoma. 2007;:1-12.
    PubMed     Related articles    Abstract available
    
    
    
86. OLIVEIRA FM , Tone LG, Simoes BP, Rego EM, et al
    Blastoid mantle cell lymphoma with t(2;8) (p12;q24).
    Leuk Lymphoma. 2007;48:2079-82.
    PubMed     Related articles   
    
    
    
87. KUBO Y , Tasaka T, Sano F, Matsuhashi Y, et al
    Amyloid-associated amyloidosis in a HCV carrier with non-Hodgkin's lymphoma who had been treated with autologous stem cell transplantation and rituximab.
    Leuk Lymphoma. 2007;48:2075-8.
    PubMed     Related articles   
    
    
    
88. MAEGAWA RO , Hussain S, Danila DC, Teruya-Feldstein J, et al
    Angioimmunoblastic T-cell lymphoma with an evolving Epstein Barr virus-positive diffuse large B-cell lymphoma with unusual clinical and pathologic findings.
    Leuk Lymphoma. 2007;48:2071-4.
    PubMed     Related articles   
    
    
    
89. SEITZ V , Stiege A, Mundlos S, Lenze D, et al
    Immunoglobulin receptor evolution in follicular lymphoma and a review of literature.
    Leuk Lymphoma. 2007;48:2063-7.
    PubMed     Related articles   
    
    
    
90. XICOY B , Ribera JM, Romeu J, Mate JL, et al
    Response to highly active antiretroviral therapy as the only therapy in an HIV-infected patient with interfollicular Hodgkin's lymphoma.
    Leuk Lymphoma. 2007;48:2058-9.
    PubMed     Related articles   
    
    
    
91. BIRGERSDOTTER A , Baumforth KR, Porwit A, Sundblad A, et al
    Three-dimensional culturing of the Hodgkin lymphoma cell-line L1236 induces a HL tissue-like gene expression pattern.
    Leuk Lymphoma. 2007;48:2042-53.
    PubMed     Related articles    Abstract available
    
    
    
92. MARTINEZ C , Salamero O, Arenillas L, Duque J, et al
    Autologous stem cell transplantation for patients with active Hodgkin's lymphoma: Long-term outcome of 61 patients from a single institution.
    Leuk Lymphoma. 2007;48:1968-75.
    PubMed     Related articles    Abstract available
    
    
    
93. KEENEY GE , Gooley TA, Pham RN, Press OW, et al
    The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation.
    Leuk Lymphoma. 2007;48:1961-7.
    PubMed     Related articles    Abstract available
    
    
    
94. MILONE G , Leotta S, Battiato K, Murgano P, et al
    Intermediate dose etoposide plus G-CSF 16 g/kg is more effective than cyclophosphamide 4 g/m(2) plus G-CSF 10 g/kg in PBSC mobilization of lymphoma patients.
    Leuk Lymphoma. 2007;48:1950-60.
    PubMed     Related articles    Abstract available
    
    
    
95. SHIMONI A , Hardan I
    Mobilization regimens prior to stem-cell collection in patients with lymphoma: How to choose?
    Leuk Lymphoma. 2007;48:1888-90.
    PubMed     Related articles   
    
    
    
96. HE H , Cheng L, Weiss LM, Chu PG, et al
    Clinical outcome of incidental pelvic node malignant B-cell lymphomas discovered at the time of radical prostatectomy.
    Leuk Lymphoma. 2007;48:1976-80.
    PubMed     Related articles    Abstract available
    
    
    September 2007
97. SHIMONI A , Nagler A
    Radioimmunotherapy and stem-cell transplantation in the treatment of aggressive B-cell lymphoma.
    Leuk Lymphoma. 2007;:1-11.
    PubMed     Related articles    Abstract available
    
    
    
98. SCARAMUCCI L , Perrotti A, Niscola P, Fratoni S, et al
    Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab.
    Leuk Lymphoma. 2007;48:1878-80.
    PubMed     Related articles       Free Full Text
    
    
    
99. ISHIKO J , Mizuki M, Yasumi M, Ujiie H, et al
    An indolent subtype of "intravascular lymphoma": A case with a 3-year history of LDH elevation.
    Leuk Lymphoma. 2007;48:1872-4.
    PubMed     Related articles       Free Full Text
    
    
    
100. OKI Y , Georgakis GV, Migone TS, Kwak LW, et al
     Elevated serum BLyS levels in patients with non-Hodgkin lymphoma.
     Leuk Lymphoma. 2007;48:1869-71.
     PubMed     Related articles       Free Full Text
     
     
     
101. MCCLUNE B , Buadi FK, Aslam N, Przepiorka D, et al
     Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma.
     Leuk Lymphoma. 2007;48:1849-51.
     PubMed     Related articles       Free Full Text
     
     
     
102. MARKASZ L , Kis LL, Stuber G, Flaberg E, et al
     Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel.
     Leuk Lymphoma. 2007;48:1835-45.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
103. KOJIMA M , Shimizu K, Nishikawa M, Tamaki Y, et al
     Primary salivary gland lymphoma among Japanese: A clinicopathological study of 30 cases.
     Leuk Lymphoma. 2007;48:1793-8.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
104. JAMALI FR , Otrock ZK, Soweid AM, Al-Awar GN, et al
     An overview of the pathogenesis and natural history of post-transplant T-cell lymphoma (corrected and republished article originally printed in Leukemia & Lymphoma, June 2007; 48(6): 1237 - 1241).
     Leuk Lymphoma. 2007;48:1780-4.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
105. LINDEROTH J , Ehinger M, Jerkeman M, Bendahl PO, et al
     CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2007;48:1774-9.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
106. WESHI AE , Akhtar S, Mourad WA, Ajarim D, et al
     T-cell/histiocyte-rich B-cell lymphoma: Clinical presentation, management and prognostic factors: report on 61 patients and review of literature.
     Leuk Lymphoma. 2007;48:1764-73.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
107. BUSSE A , Hutter G, Siehl JM, Schmittel A, et al
     A phase I/IIa clinical trial of CLAOP21 and CLAOP14 in patients with high grade non-Hodgkins lymphoma.
     Leuk Lymphoma. 2007;48:1755-63.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
108. UYTTEBROECK A , Vanhentenrijk V, Hagemeijer A, Boeckx N, et al
     Is there a difference in childhood T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma?
     Leuk Lymphoma. 2007;48:1745-54.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
109. SHAH J , Wang W, Harrough VD, Saville W, et al
     Retreatment with yttrium-90 ibritumomab tiuxetan in patients with B-cell non-Hodgkin's lymphoma.
     Leuk Lymphoma. 2007;48:1736-44.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
110. ENGELHARDT BG , Holland DW, Brandt SJ, Chinratanalab W, et al
     High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: Prognostic features and outcomes.
     Leuk Lymphoma. 2007;48:1728-35.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
111. PICARDI M , De Renzo A, Pane F, Nicolai E, et al
     Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans.
     Leuk Lymphoma. 2007;48:1721-7.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
112. DOOLITTLE ND , Jahnke K, Belanger R, Ryan DA, et al
     Potential of chemo-immunotherapy and radioimmunotherapy in relapsed primary central nervous system (CNS) lymphoma.
     Leuk Lymphoma. 2007;48:1712-20.
     PubMed     Related articles    Abstract available
     
     
     
113. ANASTASI J
     FISHing deeper for relevant disease subsets in mantle cell lymphoma.
     Leuk Lymphoma. 2007;48:1674-5.
     PubMed     Related articles   
     
     
     
114. ABRAMSON JS
     T-cell/histiocyte-rich B-cell lymphoma and the paradox of the host immune response.
     Leuk Lymphoma. 2007;48:1670-1.
     PubMed     Related articles   
     
     
     
115. YAHALOM J
     Omitting radiotherapy after attaining FDG PET-negative status following chemotherapy alone for Hodgkin lymphoma: A randomized study caveat.
     Leuk Lymphoma. 2007;48:1667-9.
     PubMed     Related articles   
     
     
     
116. EL-AGNAF MR , McCoy C, Ong YL, Eswedi AH, et al
     Infusion of rituximab over 90 minutes on an out-patient basis is safe and improves resource utilization.
     Leuk Lymphoma. 2007;48:1875-7.
     PubMed     Related articles       Free Full Text
     
     
     
117. RICHARDSON SJ , Widmer M, Zajicek J, Rule SA, et al
     Physiological doses of cannabinoids do not adversely affect MCL viability.
     Leuk Lymphoma. 2007;48:1855-7.
     PubMed     Related articles       Free Full Text
     
     
     
118. ALONCI A , Allegra A, Bellomo G, Quartarone E, et al
     Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1.
     Leuk Lymphoma. 2007;48:1852-4.
     PubMed     Related articles       Free Full Text
     
     
     
119. ZEKRI AR , Mohamed W, Bahnassy A, Refat L, et al
     Detection of simian virus 40 DNA sequences in Egyptian patients with different hematological malignancies.
     Leuk Lymphoma. 2007;48:1828-34.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
120. NELSON D , Nelson A, Hjorthagen L, Sjovall E, et al
     A limited number of IgH-primers binding to framework region 1 is sufficient to detect the majority of mature small B-cell non-Hodgkin lymphomas on formalin-fixed paraffin-embedded tissue by PCR.
     Leuk Lymphoma. 2007;48:1806-15.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     August 2007
121. HUANG Q , Su X, Ai L, Li M, et al
     Promoter hypermethylation of multiple genes in primary gastric lymphoma.
     Leuk Lymphoma. 2007;:1-9.
     PubMed     Related articles    Abstract available
     
     
     
122. SAHNI C , Desai S
     Primary testicular precursor B-lymphoblastic lymphoma: A rare entity.
     Leuk Lymphoma. 2007;:1-3.
     PubMed     Related articles   
     
     
     
123. KE X , Zhao L, Gao Z, Wang J, et al
     Higher rates of t(11;18) in Chinese patients with transformed type of MALT lymphoma suggest novel pathways for progression of the disease.
     Leuk Lymphoma. 2007;:1-10.
     PubMed     Related articles    Abstract available
     
     
     
124. RODDIE C , Cwynarski K, Craig C, Diss T, et al
     Hodgkin transformation of newly diagnosed small lymphocytic lymphoma in the gastrointestinal tract.
     Leuk Lymphoma. 2007;48:1644-6.
     PubMed     Related articles   
     
     
     
125. SIENIAWSKI M , Rimpler M, Herrmann R, Josting A, et al
     Successful carboxypeptidase G(2) rescue of a high-risk elderly Hodgkin lymphoma patient with methotrexate intoxication and renal failure.
     Leuk Lymphoma. 2007;48:1641-3.
     PubMed     Related articles   
     
     
     
126. LIM Z , Cassells R, Giles A, Cheow HK, et al
     Diffuse large B-cell lymphoma developing following treatment of Waldenstrom's macroglobulinaemia: Spontaneous resolution upon cessation of fludarabine.
     Leuk Lymphoma. 2007;48:1638-40.
     PubMed     Related articles   
     
     
     
127. KELLY RJ , O'connor SJ, Barrans SL, Johnson RJ, et al
     The t(9;14)(p13;q32) is a recurrent but rare abnormality in splenic marginal zone lymphoma.
     Leuk Lymphoma. 2007;48:1636-7.
     PubMed     Related articles   
     
     
     
128. DISPERATI P , Hicks LK, Buckstein R
     Rituximab-induced serum sickness in a patient with follicular lymphoma.
     Leuk Lymphoma. 2007;48:1633-5.
     PubMed     Related articles   
     
     
     
129. LOSSOS IS , Morgensztern D, Blaya M, Alencar A, et al
     Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma.
     Leuk Lymphoma. 2007;48:1630-2.
     PubMed     Related articles   
     
     
     
130. BISHU S , Quigley JM, Bishu SR, Olsasky SM, et al
     Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma.
     Leuk Lymphoma. 2007;48:1548-55.
     PubMed     Related articles    Abstract available
     
     
     
131. BREPOELS L , Stroobants S, de Wever W, Spaepen K, et al
     Hodgkin lymphoma: Response assessment by Revised International Workshop Criteria.
     Leuk Lymphoma. 2007;48:1539-47.
     PubMed     Related articles    Abstract available
     
     
     
132. BREPOELS L , Stroobants S, De Wever W, Spaepen K, et al
     Aggressive and indolent non-Hodgkin's lymphoma: Response assessment by Integrated International Workshop Criteria.
     Leuk Lymphoma. 2007;48:1522-30.
     PubMed     Related articles    Abstract available
     
     
     
133. CABANILLAS ME , Lu H, Fang S, Du XL, et al
     Elderly patients with non-Hodgkin lymphoma who receive chemotherapy are at higher risk for osteoporosis and fractures.
     Leuk Lymphoma. 2007;48:1514-21.
     PubMed     Related articles    Abstract available
     
     
     
134. WAGNER SD , Amen F, Trivedi PS, Horncastle D, et al
     Bcl-6 and c-Myc are rarely co-expressed in adult diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2007;48:1510-3.
     PubMed     Related articles    Abstract available
     
     
     
135. GALIMBERTI S , Nagy B, Benedetti E, Pacini S, et al
     Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen.
     Leuk Lymphoma. 2007;48:1502-9.
     PubMed     Related articles    Abstract available
     
     
     
136. TWARD J , Glenn M, Pulsipher M, Barnette P, et al
     Incidence, risk factors, and pathogenesis of second malignancies in patients with non-Hodgkin lymphoma.
     Leuk Lymphoma. 2007;48:1482-95.
     PubMed     Related articles    Abstract available
     
     
     
137. WIRTH A
     PET for follicular lymphoma: A work in progress!
     Leuk Lymphoma. 2007;48:1463-4.
     PubMed     Related articles   
     
     
     
138. MORABITO F , Gentile M
     Molecular indicators of prognosis in mantle cell lymphoma in the era of R-hyper-CVAD: Still an open issue.
     Leuk Lymphoma. 2007;48:1461-2.
     PubMed     Related articles   
     
     
     
139. BADROS A , Karakunnel J, Dawson N
     Multiple myeloma and renal cell carcinoma possible association.
     Leuk Lymphoma. 2007;48:1662-4.
     PubMed     Related articles   
     
     
     
140. MEIROW D , Baum M, Yaron R, Levron J, et al
     Ovarian tissue cryopreservation in hematologic malignancy: ten years' experience.
     Leuk Lymphoma. 2007;48:1569-76.
     PubMed     Related articles    Abstract available
     
     
     
141. BISHU S , Quigley JM, Schmitz J, Bishu SR, et al
     F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas.
     Leuk Lymphoma. 2007;48:1531-8.
     PubMed     Related articles    Abstract available
     
     
     
142. PAOLO C , Lucia F, Anna D
     Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.
     Leuk Lymphoma. 2007;48:1496-501.
     PubMed     Related articles    Abstract available
     
     
     
143. JUWEID ME
     Peripheral T-cell lymphomas: variably or routinely fluorodeoxyglucose-avid?
     Leuk Lymphoma. 2007;48:1465-7.
     PubMed     Related articles   
     
     
     July 2007
144. ZAIN J , Rotter A, Weiss L, Forman S, et al
     Valproic acid monotherapy leads to CR in a patient with refractory diffuse large B cell lymphoma.
     Leuk Lymphoma. 2007;48:1459.
     PubMed     Related articles   
     
     
     
145. RAZZAK A , Shields M, Allsup D
     Autoimmune paraneoplastic cerebellar degeneration secondary to a composite lymphoma.
     Leuk Lymphoma. 2007;48:1456-8.
     PubMed     Related articles   
     
     
     
146. MOUBAYED P , Leithauser F, Binder T, Uppenkamp M, et al
     Two cases of primary malignant NK/T-cell lymphoma in the small intestine following an aggressive clinical course: Morphological, immunohistochemical, and molecular analysis.
     Leuk Lymphoma. 2007;48:1451-5.
     PubMed     Related articles   
     
     
     
147. HE S , Roberts A, Ritchie D, Grigg A, et al
     Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma.
     Leuk Lymphoma. 2007;48:1448-50.
     PubMed     Related articles   
     
     
     
148. GIORDANO A , Perrone T, Guarini A, Ciappetta P, et al
     Primary intracranial dural B cell small lymphocytic lymphoma.
     Leuk Lymphoma. 2007;48:1437-43.
     PubMed     Related articles   
     
     
     
149. AKOZ AG , Dagdas S, Soysal H, Ozet G, et al
     Bilateral proptosis as the initial presentation of systemic nodular lymphocyte predominant Hodgkin lymphoma.
     Leuk Lymphoma. 2007;48:1434-6.
     PubMed     Related articles   
     
     
     
150. YAMANAKA R , Homma J, Sano M, Tsuchiya N, et al
     Salvage immuno-chemotherapy with a combination of rituximab, high-dose cytarabine, mitoxantrone and dexamethasone for patients with primary CNS lymphoma: A preliminary study.
     Leuk Lymphoma. 2007;48:1429-33.
     PubMed     Related articles   
     
     
     
151. AU WY , Wong KY, Wan TS, So JC, et al
     Very late relapse of B cell lymphoma masquerading as blastic transformation of chronic myeloid leukemia.
     Leuk Lymphoma. 2007;48:1414-6.
     PubMed     Related articles   
     
     
     
152. ZEIDAN A , Sham R, Shapiro J, Baratta A, et al
     Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy.
     Leuk Lymphoma. 2007;48:1410-3.
     PubMed     Related articles   
     
     
     
153. HALLDORSDOTTIR AM , Zehnbauer BA, Burack WR
     Application of BIOMED-2 clonality assays to formalin-fixed paraffin embedded follicular lymphoma specimens: Superior performance of the IGK assays compared to IGH for suboptimal specimens.
     Leuk Lymphoma. 2007;48:1338-43.
     PubMed     Related articles    Abstract available
     
     
     
154. SIMPSON L , Ansell SM, Colgan JP, Habermann TM, et al
     Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone.
     Leuk Lymphoma. 2007;48:1332-7.
     PubMed     Related articles    Abstract available
     
     
     
155. TRIMECHE M , Bonnet C, Korbi S, Boniver J, et al
     Association between Epstein-Barr virus and Hodgkin's lymphoma in Belgium: A pathological and virological study.
     Leuk Lymphoma. 2007;48:1323-31.
     PubMed     Related articles    Abstract available
     
     
     
156. BLUM KA , Johnson JL, Niedzwiecki D, Canellos GP, et al
     Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: Cancer and leukemia Group B protocol 50206.
     Leuk Lymphoma. 2007;48:1313-1319.
     PubMed     Related articles    Abstract available
     
     
     
157. AKSOY S , Harputluoglu H, Kilickap S, Dede DS, et al
     Rituximab-related viral infections in lymphoma patients.
     Leuk Lymphoma. 2007;48:1307-12.
     PubMed     Related articles    Abstract available
     
     
     
158. WEIDE R , Hess G, Koppler H, Heymanns J, et al
     High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG).
     Leuk Lymphoma. 2007;48:1299-306.
     PubMed     Related articles    Abstract available
     
     
     
159. KURTZ DM , Tschetter LK, Allred JB, Geyer SM, et al
     Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.
     Leuk Lymphoma. 2007;48:1290-8.
     PubMed     Related articles    Abstract available
     
     
     
160. LOSSOS IS
     IL-4 in lymphoma: Does the target matter?
     Leuk Lymphoma. 2007;48:1261-3.
     PubMed     Related articles   
     
     
     
161. MARTIN P , Leonard JP
     IL-4 as therapy for non-Hodgkin's lymphoma: Possibilities but major challenges.
     Leuk Lymphoma. 2007;48:1259-60.
     PubMed     Related articles   
     
     
     
162. ALI R , Beksac M, Ozkalemkas F, Ozkocaman V, et al
     Efficacy of bortezomib in combination chemotherapy on secondary plasma cell leukemia.
     Leuk Lymphoma. 2007;48:1426-8.
     PubMed     Related articles   
     
     
     
163. VERROU E , Kartsios C, Banti A, Mihou D, et al
     IgG multiple myeloma presented with ulcerative pyoderma gangrenosum.
     Leuk Lymphoma. 2007;48:1420-2.
     PubMed     Related articles   
     
     
     
164. GABRIEL IH , Chong N, Rice A, Negus R, et al
     Case 36: a difficult diagnosis in a patient with fever and progressive multi-organ failure.
     Leuk Lymphoma. 2007;48:1407-9.
     PubMed     Related articles    Abstract available
     
     
     
165. LOU YJ , Qian WB, Jin J
     Homoharringtonine induces apoptosis and growth arrest in human myeloma cells.
     Leuk Lymphoma. 2007;48:1400-6.
     PubMed     Related articles    Abstract available
     
     
     
166. RAYMAN N , Lam KH, Van Leeuwen J, Mulder AH, et al
     The expression of the peripheral cannabinoid receptor on cells of the immune system and non-Hodgkin's lymphomas.
     Leuk Lymphoma. 2007;48:1389-99.
     PubMed     Related articles    Abstract available
     
     
     
167. SANDER B , Wallblom A, Ekroth A, Porwit A, et al
     Characterization of genetic changes in MCL by interphase FISH on tissue sections.
     Leuk Lymphoma. 2007;48:1344-52.
     PubMed     Related articles    Abstract available
     
     
     
168. BERTONI F , Zucca E
     Bendamustine in lymphomas: more to combine?
     Leuk Lymphoma. 2007;48:1264-6.
     PubMed     Related articles   
     
     
     June 2007
169. AKYUZ C , Aydin GB, Cila A, Akalan N, et al
     Successful use of intraventricular and intravenous rituximab therapy for refractory primary CNS lymphoma in a child.
     Leuk Lymphoma. 2007;48:1253-5.
     PubMed     Related articles   
     
     
     
170. PATEL P , Godwin J, Velankar M, Alkan S, et al
     Nodal ALK positive anaplastic large cell lymphoma of the axilla with spontaneous regression.
     Leuk Lymphoma. 2007;48:1250-2.
     PubMed     Related articles   
     
     
     
171. CIL T , Kaplan MA, Altintas A, Pasa S, et al
     Cytosine-arabinoside induced bradycardia in patient with non-Hodgkin lymphoma: A case report.
     Leuk Lymphoma. 2007;48:1247-9.
     PubMed     Related articles   
     
     
     
172. IWUANYANWU E , Medeiros LJ, Romaguera JE, Fayad LE, et al
     Mantle cell lymphoma with a rare involvement of the testicle.
     Leuk Lymphoma. 2007;48:1242-3.
     PubMed     Related articles   
     
     
     
173. JAMALI FR , Otrock ZK, Soweid AM, Al-Awar GN, et al
     An overview of the pathogenesis and natural history of post-transplant T-cell lymphoma.
     Leuk Lymphoma. 2007;48:1237-41.
     PubMed     Related articles   
     
     
     
174. KOJIMA M , Tsukamoto N, Miyazawa Y, Iijima M, et al
     Nodal marginal zone B-cell lymphoma associated with Sjogren's syndrome: A report of three cases.
     Leuk Lymphoma. 2007;48:1222-4.
     PubMed     Related articles   
     
     
     
175. ZAIN J , Rotter A, Weiss L, Forman S, et al
     Valproic acid monotherapy leads to CR in a patient with refractory diffuse large B cell lymphoma.
     Leuk Lymphoma. 2007;48:1216-8.
     PubMed     Related articles   
     
     
     
176. TAMARU J , Tokuhira M, Nittsu N, Nakamura S, et al
     Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma.
     Leuk Lymphoma. 2007;48:1127-38.
     PubMed     Related articles    Abstract available
     
     
     
177. YAMANAKA R MD PHD , Shinbo Y, Sano M, Homma J, et al
     Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
     Leuk Lymphoma. 2007;48:1119-1126.
     PubMed     Related articles    Abstract available
     
     
     
178. GLASER SL PHD , Chang ET, Horning SJ, Clarke CA, et al
     Understanding the validity of self-reported positive family history of lymphoma in extended families to facilitate genetic epidemiology and clinical practice.
     Leuk Lymphoma. 2007;48:1110-1118.
     PubMed     Related articles    Abstract available
     
     
     
179. WILSON KS MD , Sehn LH, Berry B, Chhanabhai M, et al
     CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2007;48:1102-1109.
     PubMed     Related articles    Abstract available
     
     
     
180. ROBAK T , Lech-Maranda E, Janus A, Blonski J, et al
     Cladribine combined with cyclophosphamide and mitoxantrone is an active salvage therapy in advanced non-Hodgkin's lymphoma.
     Leuk Lymphoma. 2007;48:1092-101.
     PubMed     Related articles    Abstract available
     
     
     
181. DUNLEAVY K , Staudt LM, Wilson WH
     The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2007;48:1061-3.
     PubMed     Related articles   
     
     
     
182. HAUSWIRTH AW , Skrabs C, Schutzinger C, Gaiger A, et al
     Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas.
     Leuk Lymphoma. 2007;48:1139-49.
     PubMed     Related articles    Abstract available
     
     
     May 2007
183. BERGLUND M , Thunberg U, Fridberg M, Wingren AG, et al
     Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2007;48:1038-41.
     PubMed     Related articles   
     
     
     
184. RAJAPPA SJ , Uppin SG, Digumarti R
     Testicular relapse of primary central nervous system lymphoma.
     Leuk Lymphoma. 2007;48:1023-5.
     PubMed     Related articles   
     
     
     
185. YAMANAKA R , Homma J, Sano M, Tsuchiya N, et al
     Immuno-chemotherapy with a combination of rituximab, methotrexate, pirarubicin and procarbazine for patients with primary CNS lymphoma - A preliminary report.
     Leuk Lymphoma. 2007;48:1019-22.
     PubMed     Related articles   
     
     
     
186. SCHOLL V , Stefanoff CG, Hassan R, Spector N, et al
     Mutations within the 5' region of FAS/CD95 gene in nodal diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2007;48:957-63.
     PubMed     Related articles    Abstract available
     
     
     
187. TOBIN E , Denardo G, Zhang N, Epstein AL, et al
     Combination immunotherapy with anti-CD20 and anti-HLA-DR monoclonal antibodies induces synergistic anti-lymphoma effects in human lymphoma cell lines.
     Leuk Lymphoma. 2007;48:944-56.
     PubMed     Related articles    Abstract available
     
     
     
188. DE LATOUR RP , Chaoui D, Bourhis JH, Belhocine R, et al
     Mobilization of peripheral blood progenitor cells after DHAP regimen with or without rituximab: A large multicenter comparative study in patients with malignant lymphoma.
     Leuk Lymphoma. 2007;48:897-904.
     PubMed     Related articles    Abstract available
     
     
     
189. CAMARA DA , Stefanoff CG, Pires AR, Soares F, et al
     Immunoblastic morphology in diffuse large B-cell lymphoma is associated with a nongerminal center immunophenotypic profile.
     Leuk Lymphoma. 2007;48:892-6.
     PubMed     Related articles    Abstract available
     
     
     
190. THOMSON KJ , Peggs KS, Blundell E, Goldstone AH, et al
     A second autologous transplant may be efficacious in selected patients with Hodgkin's lymphoma relapsing after a previous autograft.
     Leuk Lymphoma. 2007;48:881-4.
     PubMed     Related articles    Abstract available
     
     
     
191. PETERSON BA , Johnson J, Shipp MA, Barcos M, et al
     High dose CHOP: A phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351.
     Leuk Lymphoma. 2007;48:870-80.
     PubMed     Related articles    Abstract available
     
     
     
192. BERG A , Visser L, Poppema S
     5'-UTR FAS mutation pattern and frequency in nodal diffuse large B-cell lymphoma similar to normal germinal center B cells.
     Leuk Lymphoma. 2007;48:851-2.
     PubMed     Related articles   
     
     
     
193. RITCHIE DS
     The role of second autografts in the treatment of Hodgkin lymphoma.
     Leuk Lymphoma. 2007;48:847-8.
     PubMed     Related articles   
     
     
     
194. TODISCO E , Sarina B, Castagna L, Mazza R, et al
     Inhibition of chronic graft-vs-host disease with retention of anti-myeloma effects by the proteasome inhibitor bortezomib.
     Leuk Lymphoma. 2007;48:1015-8.
     PubMed     Related articles   
     
     
     
195. ZWEEGMAN S , Janssen JJ, Lokhorst HM
     Immune-modulatory effects of bortezomib in GVHD.
     Leuk Lymphoma. 2007;48:853-4.
     PubMed     Related articles   
     
     
     
196. CABANILLAS F
     Dose dense CHOP: when more is not always better!
     Leuk Lymphoma. 2007;48:845-6.
     PubMed     Related articles   
     
     
     April 2007
197. NARIMATSU H , Murata M, Sugimoto K, Terakura S, et al
     Successful umbilical cord blood transplantation using a reduced-intensity preparative regimen without total body irradiation and tacrolimus plus methotrexate for prophylaxis of graft-versus-host disease in a patient with adult T-cell leukemia/lymphoma
     Leuk Lymphoma. 2007;48:841-3.
     PubMed     Related articles   
     
     
     
198. EDELINE V , Bonardel G, Brisse H, Foehrenbach H, et al
     Prospective study of 18F-FDG PET in pediatric mediastinal lymphoma: A single center experience.
     Leuk Lymphoma. 2007;48:823-6.
     PubMed     Related articles   
     
     
     
199. SABAAWY HE , Sandoval C, Guo Q, Yin C, et al
     Lymphoproliferative clonal origin of AIDS-related non-Hodgkin's lymphoma.
     Leuk Lymphoma. 2007;48:812-5.
     PubMed     Related articles   
     
     
     
200. MATSUHASHI Y , Tasaka T, Kakazu N, Nagai M, et al
     Establishment and characterization of the new splenic marginal zone lymphoma-derived cell line UCH1 carrying a complex rearrangement involving t(8;14) and chromosome 3.
     Leuk Lymphoma. 2007;48:767-73.
     PubMed     Related articles    Abstract available
     
     
     
201. HASSELBLOM S , Ridell B, Nilsson-Ehle H, Andersson PO, et al
     The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma - a population-based study.
     Leuk Lymphoma. 2007;48:736-45.
     PubMed     Related articles    Abstract available
     
     
     
202. FIGUEIREDO CP , Franz-Vasconcelos HC, Giunta G, Mazzuco TL, et al
     Detection of Torque teno virus in Epstein-Barr virus positive and negative lymph nodes of patients with Hodgkin lymphoma.
     Leuk Lymphoma. 2007;48:731-5.
     PubMed     Related articles    Abstract available
     
     
     
203. RUSSO F , Lastoria S, Svanera G, Capobianco G, et al
     Long-term follow-up study on the role of serum CA-125 as a prognostic factor in 221 newly diagnosed patients with Hodgkin's lymphoma.
     Leuk Lymphoma. 2007;48:723-30.
     PubMed     Related articles    Abstract available
     
     
     
204. PARK BB , Ryoo BY, Lee JH, Kwon HC, et al
     Clinical features and treatment outcomes of angioimmunoblastic T-cell lymphoma.
     Leuk Lymphoma. 2007;48:716-22.
     PubMed     Related articles    Abstract available
     
     
     
205. MORSCHHAUSER F , Zinzani PL, Burgess M, Sloots L, et al
     Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma.
     Leuk Lymphoma. 2007;48:708-15.
     PubMed     Related articles    Abstract available
     
     
     
206. MODY RJ , Bui C, Hutchinson RJ, Frey KA, et al
     Comparison of (18)F Flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma.
     Leuk Lymphoma. 2007;48:699-707.
     PubMed     Related articles    Abstract available
     
     
     
207. FERME C , Brice P, Michallet AS, Lederlin P, et al
     A weekly regimen with dose escalation of doxorubicin for patients with advanced Hodgkin's lymphoma: Results of a phase II study of the Groupe d'Etudes des Lymphomes de l'Adulte (GELA).
     Leuk Lymphoma. 2007;48:691-8.
     PubMed     Related articles    Abstract available
     
     
     
208. VOSE JM , Bierman PJ, Loberiza FR Jr, Bociek RG, et al
     Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation.
     Leuk Lymphoma. 2007;48:683-90.
     PubMed     Related articles    Abstract available
     
     
     
209. MORGENSZTERN D , Martin MG, Lossos IS
     Gene expression profiling in diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2007;48:669-82.
     PubMed     Related articles    Abstract available
     
     
     
210. FAYAD L , Hagemeister F
     Treatment of the patient with diffuse large B-cell lymphoma with medical co-morbidities: Newer therapies needed.
     Leuk Lymphoma. 2007;48:657-8.
     PubMed     Related articles   
     
     
     
211. PALTIEL O
     The elusive search for a viral culprit in non-EBV-associated Hodgkin lymphoma.
     Leuk Lymphoma. 2007;48:647-8.
     PubMed     Related articles   
     
     
     
212. PRO B , McLaughlin P
     Angioimmunoblastic T-Cell Lymphoma: Still a dismal prognosis with current treatment approaches.
     Leuk Lymphoma. 2007;48:645-6.
     PubMed     Related articles   
     
     
     
213. RUND D
     Multidrug resistance in lymphoma: Is it time for clinical trials?
     Leuk Lymphoma. 2007;48:643-4.
     PubMed     Related articles   
     
     
     
214. YAO R , Schneider E
     Detection of B- and T-cell-specific gene rearrangements in 13 cell lines and 50 clinical specimens using the BIOMED-2 and the original InVivoScribe primers.
     Leuk Lymphoma. 2007;48:837-40.
     PubMed     Related articles   
     
     
     
215. LOYO M , Quintanilla-Dieck Mde L, Stein B, Bolanos-Meade J, et al
     Bilateral subdural hematoma after hematopoietic stem cell transplantation: a diagnosis often overlooked.
     Leuk Lymphoma. 2007;48:835-6.
     PubMed     Related articles   
     
     
     
216. ARKENAU HT , Gordon C, Murphy F, Cunningham D, et al
     Paraneoplastic syndrome: subacute cerebellar degeneration in Hodgkin's disease.
     Leuk Lymphoma. 2007;48:819-22.
     PubMed     Related articles   
     
     
     
217. PARK M , Liu GT, Piltz-Seymour J, Wisda CL, et al
     Vision loss following denileukin diftitox treatment: a case report of possible posterior ischemic optic neuropathy.
     Leuk Lymphoma. 2007;48:808-11.
     PubMed     Related articles   
     
     
     
218. MAJOLINO I , Davoli M, Carnevalli E, Locasciulli A, et al
     Reduced intensity conditioning with thiotepa, fludarabine, and melphalan is effective in advanced m